BioTalk

04 Nov, 2024

Licensing and Collaborations in Life Sciences

By James Baillieu Sally Shorthose

There is a huge cost of bringing a pharmaceutical product to market, with estimates ranging from US$1-2 billion to take a product from...

23 Dec, 2022

By Heidi Hurdle

The UK Supreme Court has just confirmed that it will hear the appeal in FibroGen Inc v Akebia Therapeutics concerning patents for...

03 Nov, 2022

By Alison Wong Martoe Xu

TTThe second draft amendment to the Patent Examination Guidelines (the “Second Draft”) was issued by the China National Intellectual...

16 Sep, 2022

By Sally Shorthose Christopher de Mauny Pieter Erasmus +1 more...

The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property...

07 Sep, 2022

By Alison Wong Martoe Xu

On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on Chugai Pharmaceutical Co.,Ltd (the...

18 Jul, 2022

By Christopher de Mauny Domien Op de Beeck

Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations, directives and laws governing the...

19 May, 2022

By Alison Wong Martoe Xu

On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations of the Drug...

07 Apr, 2022

By Wouter Pors

Start of the Provisional Application Phase and first committee meetings The Provisional Application Phase of the Unified Patent Court...